AMPH
Amphastar Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$23.18
−2.77%Margins
Gross margin
47.7%
EBITDA margin
23.9%
EBIT margin
15.7%
Net margin
10.8%
FCF margin
20.9%
10.2%
Return on equity
4.5%
Return on assets
7.8%
Return on invested capital
0.43x
Asset turnover
$184.6M
Cash from operations
$6.82
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026